17.01.2025 • Webinar

Photoredox Catalysis

About The Event

Photoredox Catalysis

Are you ready to dive into the cutting-edge world of photoredox catalysis and reaction optimization? Join us for an exciting webinar where you'll gain invaluable insights into the latest innovations transforming the field. 

Photoredox catalysis has emerged as a powerful tool in organic synthesis, enabling the transformation of simple and readily accessible starting materials into valuable derivatives. Discover how optimizing reaction conditions, including light intensity and temperature, can lead to more efficient and selective reactions. This is your chance to stay ahead in your research and unlock new possibilities in organic synthesis!

What you will learn about:

•The versatility of photoredox catalysis in organic synthesis.

•Recent advancements in the use of commercial photoreactors.

•Strategies for optimizing reaction conditions, including light intensity and temperature.

•Extending photoredox catalysis to a broader range of nucleophiles

Speakers:

Prof. Bernhard Breit, University of Freiburg

Prof. Burkhard Koenig, Institut für Organische Chemie, Universität Regensburg

Sponsored by Merck KGaA, Darmstadt, Germany. 

This Life Science business of Merck operates as MilliporeSigma in the US and Canada

Company

Merck KGaA

Frankfurter Str. 250
64293 Darmstadt
Germany

Company contact







Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.